monoclonal antibodies

You have access
Molecular imaging of Neuroendocrine Prostate Cancer by targeting Delta-like Ligand 3
Joshua Aaron Korsen, Teja Muralidhar Kalidindi, Samantha Khitrov, Zachary V. Samuels, Goutam Chakraborty, Julia A. Gutierrez, John T. Poirier, Charles M. Rudin, Yu Chen, Michael J. Morris, NagaVaraKishore Pillarsetty and Jason S. Lewis

Journal of Nuclear Medicine January 20, 2022, jnumed.121.263221; DOI: https://doi.org/10.2967/jnumed.121.263221
You have access
Optimizing immunoPET imaging of tumor PD-L1 expression: pharmacokinetics, biodistribution and dosimetric comparisons of ⁸⁹Zr-labeled anti-PD-L1 antibody formats
ALIZEE BOULEAU, HERVE NOZACH, STEVEN DUBOIS, DIMITRI KERESELIDZE, CELINE CHEVALEYRE, CHENG-I WANG, Michael John Evans, VINCENT LEBON, BERNARD MAILLERE and Charles TRUILLET

Journal of Nuclear Medicine December 21, 2021, jnumed.121.262967; DOI: https://doi.org/10.2967/jnumed.121.262967
You have access
Affibody-mediated PNA-based pretargeted co-treatment improves survival of trastuzumab-treated mice bearing HER2-expressing xenografts
Maryam Oroujeni, Hanna Tano, Anzhelika Vorobyeva, Yongsheng Liu, Olga Vorontsova, Tianqi Xu, Kristina Westerlund, Anna Orlova, Vladimir Tolmachev and Amelie Eriksson Karlström

Journal of Nuclear Medicine October 28, 2021, jnumed.121.262123; DOI: https://doi.org/10.2967/jnumed.121.262123
You have access
The Role of ⁸⁹Zr-Immuno-PET in Navigating and Derisking the Development of Biopharmaceuticals
Guus A.M.S. van Dongen, Wissam Beaino, Albert D. Windhorst, Gerben J.C. Zwezerijnen, Daniela E. Oprea-Lager, N. Harry Hendrikse, Cornelis van Kuijk, Ronald Boellaard, Marc C. Huisman and Danielle J. Vugts

Journal of Nuclear Medicine April 1, 2021, 62 (4) 438-445; DOI: https://doi.org/10.2967/jnumed.119.239558
You have access
⁸⁹Zr-Immuno-PET: Toward a Noninvasive Clinical Tool to Measure Target Engagement of Therapeutic Antibodies In Vivo
Yvonne W.S. Jauw, Joseph A. O’Donoghue, Josée M. Zijlstra, Otto S. Hoekstra, C. Willemien Menke-van der Houven van Oordt, Franck Morschhauser, Jorge A. Carrasquillo, Sonja Zweegman, Neeta Pandit-Taskar, Adriaan A. Lammertsma, Guus. A.M.S. van Dongen, Ronald Boellaard, Wolfgang A. Weber and Marc C. Huisman

Journal of Nuclear Medicine December 1, 2019, 60 (12) 1825-1832; DOI: https://doi.org/10.2967/jnumed.118.224568
Open Access
Synergistic Effect of a Mesothelin-Targeted ²²⁷Th Conjugate in Combination with DNA Damage Response Inhibitors in Ovarian Cancer Xenograft Models
Katrine Wickstroem, Urs B. Hagemann, Véronique Cruciani, Antje M. Wengner, Alexander Kristian, Christine Ellingsen, Gerhard Siemeister, Roger M. Bjerke, Jenny Karlsson, Olav B. Ryan, Lars Linden, Dominik Mumberg, Karl Ziegelbauer and Alan S. Cuthbertson

Journal of Nuclear Medicine September 1, 2019, 60 (9) 1293-1300; DOI: https://doi.org/10.2967/jnumed.118.223701
You have access
Theranostics Using Antibodies and Antibody-Related Therapeutics
Kirsten L. Moek, Danique Giesen, Iris C. Kok, Derk Jan A. de Groot, Mathilde Jalving, Rudolf S.N. Fehrmann, Marjolijn N. Lub-de Hooge, Adrienne H. Brouwers and Elisabeth G.E. de Vries

Journal of Nuclear Medicine September 1, 2017, 58 (Supplement 2) 83S-90S; DOI: https://doi.org/10.2967/jnumed.116.186940
You have access
Development of ¹²⁴I Immuno-PET Targeting Tumor Vascular TEM1/Endosialin
Ann-Marie Chacko, Chunsheng Li, Madhura Nayak, John L. Mikitsh, Jia Hu, Catherine Hou, Luigi Grasso, Nicholas C. Nicolaides, Vladimir R. Muzykantov, Chaitanya R. Divgi and George Coukos

Journal of Nuclear Medicine March 1, 2014, 55 (3) 500-507; DOI: https://doi.org/10.2967/jnumed.113.121905

Main menu

User menu

Search

monoclonal antibodies